Impedimed (IPD)

Download button icon Download

Impedimed (IPD): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

Impedimed (IPD.AX)


Indicator:

EXPONENTIAL MOVING AVERAGE


Last Signal:

BEARISH


Trading: SELL @ $0.365
Signal Strength: STRONG
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.


Impedimed (ASX:IPD) currently has a confirmed downtrend. Recent trading has caused the EMA 15 day average to move below the closing price confirming the short term trend following indicator. Currently, the return on EMA15 is 5.8%.



An exponential moving average (EMA) is a type of moving average that is similar to a simple moving average except that more weight is given to the latest data. It’s also known as the exponentially weighted moving average. This type of moving average reacts faster to recent price changes than a simple moving average.

Calculation: Exponential Moving Average:
1) Initial SMA: n period sum / n;
2) Multiplier: (2 / (Time periods + 1));
3) EMA: {Close – EMA (previous day)} x multiplier + EMA (previous day).


PROFILE: Impedimed (IPD.AX)


Stock Exchange: ASX
Company: Impedimed
Ticker Codes: | IPD.AX | ASX:IPD |

About Impedimed (ASX:IPD):

ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.

Top 10:

Exponential Moving Average

Download button icon Download
Company Close Change (%) Volume Value Signal
TRS Reject Shop 2.34 15.8 571,078 -3 BEARISH
FIG Freedom Insurance 0.06 5.5 1,770,306 -12 BEARISH
CTD Corporate Travel Management 21.84 3.9 1,222,807 -6.3 BEARISH
KGN Kogan 2.82 3.7 1,363,532 -15.2 BEARISH
OSP Osprey Medical 0.15 3.4 156,194 -9.3 BEARISH
APA Australian Pipeline Trust 9.15 3 4,157,836 -2.5 BEARISH
SMN Structural Monitoring Systems 1.02 3 29,633 -2.6 BEARISH
SLR Silver Lake Resources 0.54 2.9 809,356 -0.4 BEARISH
DMP Domino 50.31 2.4 419,383 -4.8 BEARISH
LOV Lovisa 8 2.3 276,448 -0.7 BEARISH
back to top